Helmsley Charitable Trust Announces Funding Opportunity to Advance Disruptive Technologies for Type 1 Diabetes
Letter of Inquiry (LOI) Submission Deadline: 16 March 2018
The Leona M. and Harry B. Helmsley Charitable Trust Type 1 Diabetes (T1D) Program has launched a new Request for Proposal for the Future Technologies Initiative (FTI). The goal of the FTI is to accelerate the development of novel, early-stage, disruptive technologies that have the potential to dramatically ease the burden of managing T1D for people with type 1 diabetes.
The Future Technologies Initiative offers two tracks for funding, with projects receiving up to $750,000:
- Novel insulin and glucagon delivery technologies
- Novel sensing technologies
For all detailed information:
T1D Exchange Officially Opens the 2018 Diabetes Innovation Challenge
Call for Applications>>
Deadline for application: 1 February 2018
Global Challenge Launched to Identify, Present and Award the Next Breakthrough Solutions for Diabetes Care
The 2018 Diabetes Innovation Challenge will award $250,000 in cash and in-kind services, which will be divided among three winners. A People's Choice award will be given to the recipient of the most votes during the public voting period.
The Diabetes Innovation Challenge welcomes both type 1 and type 2 diabetes opportunities as products developed for one disease may have cross-utility for the other. The Diabetes Innovation Challenge is open to all academic and for-profit inventors, innovators and companies developing or seeking to develop medical devices, diagnostics, therapeutics, digital health technologies and clinical care improvements in diabetes.
For more information visit the T1D Exchange website and read all details in this press release:
T1D Exchange_2018 Diabetes Innovation Challenge_Press release.pdf